
3B Blackbio’s Market Evaluation Revised Amidst Challenging Financial Trends
2025-11-30 10:24:233B Blackbio has experienced a revision in its market evaluation, reflecting shifts in its financial and technical outlook. This adjustment comes amid a backdrop of subdued sales growth, valuation concerns, and a bearish technical stance, all contributing to a more cautious market perspective on the healthcare services company.
Read More
3B Blackbio DX Hits Intraday High with Strong Surge in Healthcare Services Sector
2025-11-25 14:32:483B Blackbio DX recorded a robust intraday performance on 25 Nov 2025, touching a day’s high of ₹1280, marking an 8.26% rise. This surge stands out amid a broader market environment where the Sensex showed a mild decline, underscoring the stock’s notable trading momentum within the healthcare services sector.
Read MoreWhy is 3B Blackbio falling/rising?
2025-11-25 01:12:29Recent Price Movements and Market Performance The stock has been under pressure for several sessions, registering losses for four consecutive days and declining by 11.76% over this period. On the day in question, the share price hit a new 52-week low of ₹1,175.3, underscoring the bearish sentiment among investors. Despite an intraday high of ₹1,329.9, the weighted average price skewed closer to the day’s low, indicating that more volume was traded at lower price levels. This pattern, combined with an intraday volatility of 6.17%, highlights the stock’s heightened price fluctuations and investor uncertainty. Further compounding the negative momentum, 3B Blackbio is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages....
Read More
3B Blackbio DX Hits Intraday Low Amid Price Pressure and Market Volatility
2025-11-24 14:47:073B Blackbio DX experienced a notable decline today, touching an intraday low of ₹1,185.3, marking a fresh 52-week low as the stock faced significant price pressure amid broader market fluctuations and sector underperformance.
Read More
3B Blackbio DX Falls to 52-Week Low of Rs.1226.1 Amidst Prolonged Downtrend
2025-11-24 14:37:32Shares of 3B Blackbio DX, a player in the Healthcare Services sector, touched a fresh 52-week low of Rs.1226.1 today, marking a significant decline amid a sustained downward trend over recent sessions.
Read MoreIs 3B Blackbio technically bullish or bearish?
2025-11-18 08:29:40As of 17 November 2025, the technical trend for 3B Blackbio has changed from mildly bearish to bearish. The current stance is bearish with moderate strength. Key indicators driving this conclusion include the daily moving averages indicating bearish momentum, and the weekly and monthly Bollinger Bands also signaling bearish conditions. The MACD shows a mildly bullish signal on the weekly chart but is mildly bearish on the monthly, indicating mixed signals across time frames. Overall, the bearish trend is reinforced by the Dow Theory, which is mildly bearish on both weekly and monthly assessments....
Read More
3B Blackbio DX Faces Mixed Technical Signals Amid Market Volatility
2025-11-18 08:07:573B Blackbio DX, a small-cap healthcare services company, has experienced significant stock fluctuations, with a recent trading range indicating volatility. Technical indicators present mixed signals, reflecting complex market sentiment. Despite recent challenges compared to the Sensex, the company has demonstrated substantial long-term growth over three and five years.
Read More
3B Blackbio DX Hits New 52-Week Low at Rs. 1248 Amid Market Struggles
2025-11-17 10:48:333B Blackbio DX has hit a new 52-week low, reflecting a significant downturn for the small-cap healthcare services firm. The stock has underperformed its sector and experienced high volatility. Over the past year, it has declined notably, contrasting with broader market gains, while facing challenges in sales and profit metrics.
Read More
3B Blackbio DX Hits Day Low of Rs 1261.9 Amid Price Pressure
2025-11-17 10:01:283B Blackbio DX, a small-cap healthcare services company, has faced notable volatility, reaching a 52-week low while underperforming its sector. The stock fluctuated significantly during the trading session and is currently below key moving averages, reflecting a bearish trend amid a generally positive broader market.
Read MoreBoard Meeting Intimation for Consideration And Approval Of The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Nine Months Ended On 31St December 2025.
30-Jan-2026 | Source : BSE3B Blackbio Dx Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2026 inter alia to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended on 31st December 2025.
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
06-Jan-2026 | Source : BSECertificate under Reg.74(5) of SEBI (DP)Regulations 2018
Announcement under Regulation 30 (LODR)-Newspaper Publication
30-Dec-2025 | Source : BSESpecial Window for Re-lodgement of Transfer Requests of Physical Shares
Corporate Actions
No Upcoming Board Meetings
3B Blackbio DX Ltd has declared 40% dividend, ex-date: 19 Sep 25
No Splits history available
No Bonus history available
No Rights history available